1044559-92-3

Upstream product

• 35079-19-7 trans-(1R,2R)-1,2-Bis(methoxycarbonyl)-4-oxocyclopentane 
• 1044559-77-4 4-methoxy-6-(4-methoxy-benzyloxy)-2-phenyl-pyrimidine 
• 862174-61-6 3-oxo-2-oxa-bicyclo[2.2.1]heptane-5-carboxylic acid tert-butyl ester 
• 862259-02-7 trans-(3R,4R)-3,4-bis(methoxycarbonyl)cyclopentanol 
• 862174-60-5 (1R,4R,5R)-3-oxo-2-oxabicyclo[2.2.1]heptane-5-carboxylic acid 
• 259214-54-5 ethyl (1R,2S)-1-amino-2-vinylcyclopropanecarboxylate hydrochloride 
• 862174-62-7 (1R,2R,4S)-2-((1R,2S)-1-ethoxycarbonyl-2-vinyl-cyclopropylcarbamoyl)-4-hydroxy-cyclopenteanecarboxylic acid tert-butyl ester 
• 59081-26-4 6-methoxy-2-phenylpyrimidin-4-ol 
• 603-35-0 triphenylphosphine 

Downstream Products

• 1044559-95-6 2-(1-ethoxycarbonyl-2-vinyl-cyclopropylcarbamoyl)-4-(6-methoxy-2-phenyl-pyrimidin-4-yloxy)-cyclopentanecarboxylic acid 
• 1044560-05-5 17-(6-methoxy-2-phenylpyrimidin-4-yloxy)-13-methyl-2,14-dioxo-3,13-diaza-tricyclo[13.3.0.0*4,6*]octadec-7-ene-4-carboxylic acid 
• 1044560-02-2 17-(6-methoxy-2-phenylpyrimidin-4-yloxy)-13-methyl-2,14-dioxo-3,13-diazatricyclo[13.3.0.0*4,6*]octadec-7-ene-4-carboxylic acid ethyl ester 
• 1044559-99-0 1-{[2-(hex-5-enyl-methyl-carbamoyl)-4-(6-methoxy-2-phenylpyrimidin-4-yloxy)cyclopentanecarbonyl]-amino}-2-vinyl-cyclopropanecarboxylic acid ethyl ester 
• 1044558-82-8 thiophene-2-sulfonic acid [17-(6-methoxy-2-phenylpyrimidin-4-yloxy)-13-methyl-2,14-dioxo-3,13-diaza-tricyclo[13.3.0.0*4,6*]octadec-7-ene-4-carbonyl]-amide 
• 1044558-77-1 1-methyl-cyclopropanesulfonic acid [17-(6-methoxy-2-phenylpyrimidin-4-yloxy)-13-methyl-2,14-dioxo-3,13-diaza-tricyclo[13.3.0.0*4,6*]octadec-7-ene-4-carbonyl]-amide 
• 1044558-80-6 N-[17-(6-methoxy-2-phenylpyrimidin-4-yloxy)-13-methyl-2,14-dioxo-3,13-diaza-tricyclo[13.3.0.0*4,6*]octadec-7-ene-4-carbonyl]-benzenesulfonamide 

Relevant academic research and scientific papers

PYRIMIDINE SUBSTITUTED MACROCYCLIC HCV INHIBITORS

Compounds of the Formula (I) including a stereoisomer thereof, or an N-oxide, a pharmaceutically acceptable addition salt, or a pharmaceutically acceptable addition solvate thereof; useful as HCV inhibitors; processes for preparing these compounds as well as pharmaceutical compositions comprising these compounds as active ingredient.